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One-Year Clinical Outcomes of a Two-Step Surgical
Management for Keratoconus—Topography-Guided
Photorefractive Keratectomy/Cross-Linking After Intrastromal
Corneal Ring Implantation
Waleed S. Al-Tuwairqi, M.D., Ph.D., Uchechukwu L. Osuagwu, O.D., M.Sc.,
Haya Razzouk, M.D., and Kelechi C. Ogbuehi, Ph.D.
AU2
AU3
Purpose: To present the results of same-day topography-guided photo-
refractive keratectomy (TG-PRK) and corneal collagen cross-linking (CXL)
after intrastromal corneal ring (ISCR) implantation in patients with keratoconus.
Methods: Thirty-three patients (41 eyes) aged between 19 and 45 years
were included in this prospective study. All patients underwent a femtosec-
ond laser–enabled (Intralase FS; Abbott Medical Optics, Inc.) placement of
intracorneal ring segments (Kerarings; Mediphacos, Brazil). Uncorrected
distance visual acuity (UDVA), corrected distance visual acuity (CDVA),
and keratometry readings remained stable for 6 months. Same-day PRK and
CXL was subsequently performed in all patients.
Results: After 12 months ofAU6 completion of the procedure, mean UDVA in log
of minimal angle of resolution was significantly improved (0.7460.54–
0.1060.16); CDVA did not improve significantly but 85% of eyes maintained
or gained multiple lines of CDVA; mean refraction spherical equivalent
(23.0361.98 to 20.0460.99 D), all keratometry readings were significantly
reduced, from preoperative values, but coma did not vary significantly from
preoperative values. Central corneal thickness and corneal thickness at the
thinnest point were significantly (P,0.0001) reduced from 519.76629.33
and 501.87631.50 preoperatively to 464.71636.79 and 436.55647.42 post-
operatively, respectively. Safety and efficacy indices were 0.97 and 0.88,
respectively. From 6 months and after 1 year of follow-up, further significant
improvement was observed only for UDVA (P,0.0001).
Conclusions: Same-day combined TG-PRK and CXL after ISCR implan-
tation is a safe and effective option for improving visual acuity and visual
function and ceases progression of the ectatic disorder. The improvements
recorded after 6 months of follow-up were maintained or improved upon 1
year after the procedure.
Key Words: Keratoconus—Corneal collagen cross-linking—Distance
visual acuity—Satisfaction—Intrastromal corneal ring implantation.
(Eye & Contact Lens 2015;00: 1–8)
K eratoconus is a progressive non-inflammatory, asymmetric,and usually bilateral ectatic disease of the cornea character-
ized by localized corneal thinning, visual distortion, corneal steep-
ening, and central corneal scarring.1 Its onset is generally at puberty
but often progresses until the fourth decade of life, when it usually
stabilizes.2 Its prevalence in the general population is reported to be
about 1 in 2,000 (0.0005%) people,2 and 1 in 1,750 white Euro-
peans aged between 10 and 44 years are affected with the disease
and this estimate rises to 1 in 450 (0.002%) in South Asians.3 In
Saudi Arabia, an incidence of 20/100,000 (0.002%) was reported
in one province a decade ago,4 and an increase in the number of
referrals because of keratoconus has also been observed.5
Corneal collagen cross-linking (CXL) uses riboflavin and UV-A
irradiation to strengthen the cornea by augmenting the crosslinks
between collagen fibrils, thereby stabilizing the condition and
effectively stalling the progression of keratoconus and pellucid
marginal degeneration.6–8 CXL alone may prevent topographic and
refractive progression but it leads to minimal improvement in vision
quality of patients and induces corneal flattening.7,9 However, a com-
bination of various techniques like conductive keratoplasty,10 photo-
refractive keratectomy (PRK),11–14 intrastromal corneal ring (ISCR)
implantation plus PRK,15,16 non–topography-guided PRK after ISCR
implantation,17 and simultaneous wavefront-guided PRK18 with CXL
maximizes the results by providing an overall additive effect on
visual acuity, keratometry, and stability of the condition.11,15,16,19–23
Same-day simultaneous topography-guided PRK and CXL was
shown to be superior to sequential CXL with later PRK in the
visual rehabilitation of progressing keratoconus.24 Despite the re-
ported safety and improvements in visual functions associated with
same-day combined surgical approach, few studies have followed
up the patients beyond 6 months postoperatively and the procedure
is uncommon among practitioners in the Middle East despite the
increasing number of keratoconus referrals.5 This study aim to
evaluate the efficacy of ISCR implantation followed no less than
6 months later by same-day topography-guided photorefractive
keratectomy (TG-PRK) combined with CXL for visual rehabilita-
tion in patients with keratoconus (two-step procedure). To enable
the comparison of the outcomes of this study with those of other
studies, to enhance easy recognition, and to allow the reader to
quickly find some basic information,10,12,20–23 the results were re-
ported using the standards outlined for reporting outcomes of
refractive surgery but often ignored by researchers.25,26
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SUBJECTS AND METHODS
Subject Population
Forty-one eyes of 33 patients with keratoconus (24 men [72.7%]
and 9 women [27.3%]) of mean age 28.466.7 years (range: 19–45
years) were randomly recruited from a pool of patients seeking
relief from their ocular condition and who were scheduled to
undergo a combined surgical procedure for management of their
existing keratoconus condition. Informed consent was obtained
after the hospital research review board approved the study pro-
tocol. The study conformed to the tenets of the Declaration of
Helsinki (1975), as revised in Edinburgh 2000.
All patients underwent ISCR implantation and were followed up
for at least 6 months and at most 9 months, until stabilization of
refraction was achieved before same-day TG-PRK and CXL was
performed. These patients were included if the patients were
interested in the study, were intolerant to contact lens wear or were
not interested in participating in the study, showed moderate
keratoconus, poor spectacle vision, and progression in keratoconus
observed over the previous 6 months. The exclusion criteria were the
presence of any of the following conditions: central or paracentral
corneal scarring; central pachymetry less than 400 mm, as measured
by the Galilei Dual Scheimpflug Analyzer (Ziemer, Switzerland),
pregnancy or lactation; severe dry-eye disease; systemic autoimmune
disease; and/or a history of herpetic keratitis. Keratoconus was
graded based on Amsler–Krumeich classification in accordance with
the distribution area of the ectasia as has been described by Gómez-
Miralles et al.27 However, progression of keratoconus was defined as
one or more of the following changes over a period of 6 months: an
increase of $1.00 D in K-max, an increase of $1.00 D manifest
cylinder, or an increase of $0.50 D in manifest refraction spherical
equivalent. All patients were seeking relief from symptoms arising
from their refractive errors.
Data Collection
Clinical evaluation of general and ocular health was performed
preoperatively. For all patients, one Optometrist assessed the
following visual parameters, preoperatively, after 6 and 12 months
of performing the two-step procedure (ISCR implantation followed
no less than 6 months by same-day TG-PRK and CXL): uncorrected
distance visual acuity (UDVA [log of minimal angle of resolution;
logMAR]); corrected distance visual acuity (CDVA [logMAR]);
mean manifest objective cylinder; mean objective sphere; central
corneal thickness (CCT) by ultrasound pachymeter; topographical
keratometry values; and corneal coma-like root mean square assessed
over a 4.5 mm of pupil size. The keratometry values and coma were
obtained using the Schwind Corneal wavefront Analyzer (Schwind
Eye-tech-Solutions; GmbH & Co., Kleinostheim, Germany). All data
were entered into a Microsoft Excel 2007 spreadsheet (Microsoft, Inc,
Redmond, WA). The means, standard deviations, and minimum and
maximum values were calculated and presented descriptively using
standard graphs and tables used for reporting refractive surgery results
as recommended by Waring et al.26
Surgical Procedures
All procedures—the first step (ISCR) and the second step (PRK
and CXL)—in all patients were performed at the Elite Medical
Centre Riyadh, by the same Ophthalmologist (W.S.A.-T.) under
conditions similar to what is used in refractive surgery suites. As
a first step, all eyes underwent femtosecond laser–enabled Intralase
FS 150 kHz (Intralase Corp./Abbott Medical Optics, Inc., Abbott
Park, IL) placement of ICRs using the Keraring (Mediphacos,
Brazil) AU7with a 1.30 mJ default energy setting. Segment sizes were
determined according to the nomogram provided by the manufac-
turer. Depth of the ring channels was set at 75% to 80% of the
thinnest pachymetry reading, and the tunnel was programmed for
an inner diameter of 4.4 mm and an outer diameter of 5.6 mm, the
entry cut thickness was 1 mm (at the steepest topographic axis). At
the end of the surgery, diclofenac sodium 0.1% (Voltaren) and
tobramycin/dexamethasone eye drops were administered, a bandage
contact lens (Air Optix Ciba Vision of material, lotrafilcon B,
diameter 14.0 mm, base curve 8.6 mm, and Dk of 140 barrers)
was fitted, and slitlamp examination was conducted. Approxi-
mately 3 to 5 days later, the bandage contact lens was removed
after the epithelial defect at the site of incision had closed.
Following stabilization of refraction after ISCR implantation, the
patients underwent a second step of topography-guided PRK followed
by same-day riboflavin–UV-A CXL during same session. Transepi-
thelial mode to remove the epithelium was performed in all cases by
phototherapeutic keratectomy (PTK) using the Schwind Amaris laser
platform (Schwind Eye-tech-Solutions; GmbH & Co.), so as to
smooth the anterior irregular cornea. To minimize tissue ablation
and reduce the risk of iatrogenic ectasia,12 the PTK ablation was
performed to remove 50 mm of the central 6.5 mm of corneal epithe-
lium before performing TG-PRK treatments with a 6-mm optical
zone. We aimed to reduce irregular astigmatism by normalizing the
cornea while treating part of the refractive error. Corneal wavefront
errors were calculated using the topography data from the Corneal
Wavefront Analyzer, a standard eye model, and ray tracing. The
Schwind Corneal Wavefront Analyzer measures the difference
between the anterior topography and the best sphere and converts
the corneal plane from its current state to the best sphere. This profile
was shown to be reliable28 and with it, we tried to achieve emmetropia
in one surgical step. The instrument also has the capability of selective
treatment for coma or spherical aberration alone. The aim of this
treatment was to normalize the cornea by reducing irregular astigma-
tism while treating part of the refractive error. Mitomycin C (0.02
mg/mL) was then applied for 30 sec for all TG-PRK procedures.
Shortly after PRK, the CXL treatment was initiated by instilling
0.1% riboflavin solution in the center of the cornea every 2 to
3 min for 30 min to saturate the cornea. During the procedure, the
absorption of riboflavin across the corneal stroma and anterior
chamber was confirmed through examination under the slitlamp.
Hypotonic riboflavin (0.1% with no dextran) was used for 10 min
to induce corneal swelling to at least 400 mm, but when the stromal
bed thickness was less than 400 mm, isotonic riboflavin was used.
Thinnest and CCT were continuously monitored using ultrasonic
pachymeter to ensure that none dropped below 400 mm. The UV-A
irradiation was performed at the central 8.0 mm diameter of the
cornea using a UVX system (Peshke, Inc.) AU8of wavelength 365 nm
for 30 min at irradiance of 3 mW/cm2, total energy 5.4 J/cm2;
during this time, riboflavin drops were instilled every 2 min. After
CXL, the corneal surface was irrigated with a cold balanced salt
solution kept at 4°C, same antibiotic and corticosteroid eye drops
used in the first procedure were administered, a bandage contact
lens was fitted until full re-epithelialization (between 3 and 5 days)
before it was removed, and the eyes were examined at the slitlamp.
Postoperative medication included 0.1% diclofenac sodium
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(Voltaren) eye drops four times a day for 2 days and tobramycin/
dexamethasone drops four times daily. Corneal haze was subjec-
tively quantified on a slitlamp by the following grading scale: 0 for
no corneal haze or totally transparent cornea; 1 for slight corneal
haze or slight loss of transparency; 2 for moderate haze and iris
details seen; and 3 for exaggerated haze or when iris details are
hardly seen. The Safety Index was calculated as the ratio: post-
keraring placement CDVA divided by baseline CDVA (both in
logMAR units). The Efficacy Index was calculated as the ratio:
post-keraring placement UDVA divided by the baseline CDVA
(both in logMAR units). A satisfaction questionnaire that was used
in a previous study23 was completed by every patient.
Statistical Analysis
The normality of data distribution was checked by the
Kolmogorov–Smirnov test. To study the differences in outcome
parameters preoperative, 6 months and after 1 year postoperative,
a repeated-measures analysis of variance was conducted for mean
values of all tested parameters except for CCT and coma, where
a Student t test analysis was used to compare the baseline with 1
year postoperative outcome values. All statistical analyses were
conducted using the GraphPad Prism software (version 6.00;
Graph pad Software, Inc., La Jolla, CA). Differences were consid-
ered to be statistically significant when the P value was less than
0.05, and with 40 eyes the study had a power of 85% as calculated
using the G* Power software 3.1.10 version. For satisfaction anal-
ysis, a score of 12 or more and less than 12 indicated that patient
was satisfied and dissatisfied, respectively.
RESULTS
Of the 41 eyes that underwent the two-step procedure, 39 eyes
(95.1%) had paracentral cones and 2 eyes (4.9%) had a central cone
(i.e., when the apex—the highest point on the posterior elevation
toric ellipsoid float—is between the 3- and 5-mm circles or within
the central 3-mm circle, respectively). The mean follow-up period
after the second step procedure was 14.865.2 months (range:
10–24 months). T1Table 1 shows the preoperative (baseline) and
postoperative (at 6 months and after 1 year follow-up) visual and
refractive outcomes.
Visual Outcomes
There was a statistically significant improvement in UDVA
(P,0.0001) at final follow-up postoperatively. Post hoc analysis
showed that between 6 months postoperative and after 1 year of
completing the second procedure, measured UDVA also improved
(P,0.0001) and CDVA remained unchanged (Table 1). At the
final follow-up visit, approximately 61% of the eyes (28 eyes)
achieved at least 20/25 monocular UDVA ( F1Fig. 1) and no eyes lost
more than two Snellen lines of CDVA. Safety and efficacy indexes
for the 41 eyes were 0.97 and 0.88, respectively.
Refractive Outcomes
All refractive components were statistically significantly reduced
(P,0.0001, for all comparisons) after 6 months and after 1 year of
follow-up, but between both follow-up intervals, no statistically
significant differences were observed in all refractive outcomes
(P.0.05, for all comparisons) as shown in Table 1.
The changes in refractive astigmatism and mean refraction
spherical equivalent (MRSE) 1 year postoperatively are plotted
in F3Figures 3 and 4, respectively. The figures show that in 71% of
eyes (21 eyes), refractive astigmatism was #1.00 D (Fig. 3) and
the MRSE was within 1.0 D of emmetropia in 73.2% (30 eyes) of
eyes ( F4Fig. 4).
F5Figure 5 shows the achieved spherical equivalent correction
plotted at 1 year postoperatively against the attempted correction.
TABLE 1. Mean Preoperative (Baseline), 6 Months Postoperative, and 1 Year Postoperative Intrastromal Corneal Ring Implantation Followed by
Same-Day Topography-Guided Photorefractive Keratectomy Combined With Corneal Collagen Cross-linking Data and the Results of
Comparative Analysis
Outcomes Baseline 6 mo Postop Pa 12 mo Postop Pb Pc
UDVA (logMAR) 0.7460.54 (0.05 to 3.00) 0.1260.26 (20.10 to 2.00) ,0.0001 0.1060.16 (20.10 to 0.40) ,0.0001 ,0.0001
CDVA (logMAR) 0.0460.12 (20.10 to 0.48) 0.0460.11 (20.10 to 0.48) .0.05 0.0560.10 (20.10 to 0.48) .0.05 .0.05
Ksteep (D) 46.1362.10 (41.45 to 51.51) 43.0362.37 (38.15 to 48.23) ,0.001 43.2062.29 (39.10 to 47.34) ,0.001 .0.05
Kflat (D) 43.7961.80 (40.40 to 48.54) 41.4661.20 (37.56 to 45.12) ,0.001 41.5062.02 (37.13 to 44.78) ,0.001 .0.05
Kaverage (D) 44.9661.83 (41.13 to 50.03) 42.2462.12 (38.02 to 46.29) ,0.001 42.3562.11 (38.12 to 45.66) ,0.001 .0.05
Sphere (D) 21.9362.20 (27.00 to 2.00) 0.2060.87 (21.25 to 2.50) ,0.0001 0.3461.04 (21.25 to 2.75) ,0.0001 .0.05
Manifest Cyl (D) 22.2061.47 (26.00 to 0.00) 20.8160.80 (22.75 to 0.00) ,0.0001 20.7660.74 (22.25 to 0.50) ,0.0001 .0.05
Topographic
astigmatism
(D)
22.3361.36 (26.20 to 20.30) 21.5760.96 (23.88 to 20.27) ,0.0001 21.7060.93 (23.94 to 20.48) ,0.0001 .0.05
MRSE (D) 23.0361.98 (27.13 to 20.25) 20.2060.91 (22.00 to 2.50) ,0.0001 20.0460.99 (21.75 to 2.50) ,0.0001 .0.05
Coma (mm) 1.0860.66 (0.15 to 3.80) 0.8360.60 (0.06 to 3.57) ,0.05 0.7960.63 (0.22 to 3.54) .0.05 .0.05
CCT (mm) 519.76629.33 (448.00 to 590.00) 462.51629.49 (398.00 to 539.00) ,0.0001 464.71636.79 (353.00 to 546.00) ,0.0001 .0.05
CT (mm)
@thinnest
location
501.87631.50 (420.00 to 573.00) 434.53633.26 (366.00 to 513.00) ,0.0001 436.55647.42 (310.00 to 527.00) ,0.0001 .0.05
For CCT and coma, results are one-way measures analysis of varianceAU13 .
aP values of post hoc analysis of repeated-measures analysis of variance 6 months postoperative versus baseline, 1 year postoperative versus
baseline.
bP values of post hoc analysis of repeated-measures analysis of variance 1 year postoperative versus baseline.
cP values of post hoc analysis of repeated-measures analysis of variance 6 months postoperative versus 1 year postoperative.
CCT, central corneal thickness; CDVA, corrected distance visual acuity in logMAR; D, diopter; MRSE, mean refraction spherical equivalent;
UDVA, uncorrected distance visual acuity in logMAR.
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In this figure, the solid line represent the slope while the short
dashed lines and the long dashed lines represent points within
61.00 D and within 61.5 D (i.e., standard deviation of attempted
MRSE), respectively. It shows a weak correlation that was close to
being statistically significant (R2¼0.09, P¼0.055). The difference
between means of attempted and achieved spherical equivalent
refraction was 20.1261.5 D with a 95% confidence interval range
of 22.98 and 2.74 D (P¼0.5909). Seven eyes (17%) achieved
emmetropia (MRSE¼+0.50 to 20.25 D) at the final follow-up.
Keratometer and Corneal Thickness Values
There was a statistically significant reduction in all K values
(mean Kflat, Ksteep, and Kaverage; P,0.0001 for all), at the final
follow-up visit, but no significant change was observed between
all K values obtained at 6 months and after 12 months of complet-
ing the procedure (P.0.05, for all comparisons) (Table 1).
Central corneal thickness and CTAU9 at the thinnest point were
statistically significantly reduced from preoperative values at 6
months and at 12 months postoperatively (P,0.0001, for both
comparisons) but did not change between both follow-up visits
(P.0.05, for 6 months versus after 12 months). However, coma,
which was standardized at a wavefront diameter of 6 mm for all
eyes, was significantly reduced at 6 months but remained similar to
preoperative values after 12 months of completing the procedure
(P.0.05, Table 1).
Improvement in Visual Acuity and Refraction
The follow-up period in these eyes revealed that the visual and
refractive outcomes, which improved at 6 months, were maintained
up to 1 year after the two-step surgical procedure. Except for
UDVA, there were no statistically significant changes in the
CDVA, spherical, cylindrical error between 6 and 12 months after
surgery as shown in Table 1. F6Figure 6 shows the improvement in
mean spherical equivalent refraction from at both postoperative
follow-up intervals.
Complications
Four eyes (9.8%) were undercorrected, 4 (9.8%) were over-
corrected, and 3 eyes (7.3%) had coma that exceeded 1.5 mm.
None of the tested eyes had any visible haze during the whole
follow-up and none had any serious complication 1 year
postoperatively.
FIG. 1. Preoperative corrected distance visual acuity
and 1 year postoperative uncorrected distance visual
acuity.
FIG. 2. Change in Snellen lines of corrected dis-
tance visual acuity (CDVA).
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Subjective Questionnaire Outcomes
Thirty-three patients (completion rate, 80.5%) completed the
questionnaire. Majority of the patients (26/33, 78.8%) reported that
they were satisfied with the outcome of their procedure; 7 patients
(21.2%) stated that they were not satisfied. Two of the subjects
who were dissatisfied were the ones who had coma that was
$1.5 mm postoperatively.
DISCUSSION
In this prospective study, we wanted to determine whether the
treatment of early stage keratoconus by ISCR followed up not
less than 6 months and at most 9 months later by same-day TG-
PRK plus CXL (two-step procedure) leads to improvement in
visual outcomes even after 1 year. We also sought to show the
results using a protocol that should be used25,26 but is not com-
monly used for reporting graphical results of post-keratoconus
surgical treatment. This protocol would enhance easy, practical,
and more accurate comparison of the outcomes with those of
future studies. Intrastromal corneal ring implantation with the
aid of a femtosecond laser was performed as a first-step proce-
dure. We found very satisfactory refractive outcomes in the effi-
cacy index (0.88), which was slightly better than that reported in
a previous study after 6 months of follow-up23 but lower than the
1.6 reported in another study of 1-year postoperative outcomes.16
Predictability was very good as 80.5% of treated eyes were within
the SD (60.45) of the attempted MRSE, and there was no statis-
tically significant difference between the attempted and achieved
MRSE values. The MRSE was 20.50 D after 12 months of
surgery, with a majority (73%) of the eyes being within 61.00
D. In addition, mean manifest astigmatism decreased significantly
(from 22.20 to 20.76 D) after 12 months of the procedure.
Regarding visual outcomes, the efficacy was good (0.98) as more
than 60% of eyes had a postoperative UDVA of 20/25 or better
(Fig. 1). Although approximately 85% of eyes maintained AU10or
gained multiple lines CDVA ( F2Fig. 2), 15% of eyes (15%) lost
one or two lines of CDVA. Overall, the CDVA improved after
12 months of the procedure but this improvement did not reach
a statistically significant level, which was the target for perform-
ing this procedure in two steps (Table 1).
FIG. 3. Preoperative and 1 year postoperative
refractive astigmatism in Diopters (D).
FIG. 4. Spherical equivalent refractive accuracy in
Diopters (D).
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The efficacy and predictability of the combined procedure in the
treatment of keratoconus are supported by recent reports.T2 Table 2
summarizes the main results of the studies of TG-PRK plus CXL.
Generally, it has been shown that combining TG-PRK with CXL
lead to greater improvements in visual functions and halts progres-
sion of the disease. In the sequence, Li et al.29 suggestedAU11 that PRK
followed by CXL was better than CXL followed by PRK because
removing the cross-linked stiffer anterior cornea may minimize the
benefit of CXL in the latter procedure. Wavefront-guided PRK
combined with CXL showed similar improvements in the visual
outcomes at 6 months that were maintained through 12 months
postoperative,18 which were similar to our result. The satisfactory
visual, keratometry, and topography results, which were also
shown in the current study after 6 and 12 months of this two-
step procedure, further confirm that the combined procedures
complement one another and that the improvements in vision were
maintained or sometimes improved upon, after 12 months of the
procedure. Generally, same-day combined surgical procedures
are more effective than sequential treatments in improving the
corneal shape in patients with keratoconus.24,29,30 However, practi-
tioners were cautioned on the likelihood of overcorrecting patients
during the surface normalization.31 In this study, four eyes were
overcorrected.
Our results showed a significant reduction in the preoperative
topographic astigmatism, Ksteep, Kflat, and Kaverage values 12
months after the two-step procedure. In addition, we observed that
the combined therapy significantly improved UDVA and CDVA
was the same and this was the target during the procedure. Simi-
larly, CCT and CT at thinnest point were further reduced by
approximately 55.06 and 68.56 mm, respectively, at the completion
FIG. 5. Attempted spherical equivalent refractive
(SER) error versus achieved SER in Diopters (D). Solid
line indicates the slope; shorter dashed lines are
points within 61.00 D; shorter dashed lines are
points within 61.5 (i.e., the standard deviation of
achieved SER).
FIG. 6. Stability of spherical equivalent refraction in
Diopters (D).
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of the procedure (Table 1). There was a significant reduction in
coma (which is the hallmark of keratoconus) from 1.08 mm pre-
operatively to 0.83 mm at 6 months postoperatively. However,
despite the mean reduction in coma observed after 12 months of
completion of the procedure, the coma root mean square values
measured at final visit was similar to baseline values. A possible
explanation for this could be the instrument used in the assessment
of corneal aberrations in this study. Most wavefront analysers are
based on the Hartmann–Shack principle, including the Schwind
Ocular Wavefront Analyser, which has a wavefront sensor with
a resolution of 210 mm and a maximum of 1,452 measuring
points,32 but the Schwind Corneal Wavefront Analyser used in this
study obtains measurements by calculating corneal topography
data with ray tracing and a standardized eye model. Both instru-
ments are reliable and have been recommended for use in refractive
surgery, even though the Hartmann–Shack device was favored.28
Although studies12–16,18–21,23,33,34 have shown similar significant
improvements in most of the tested visual functions, they have
been conducted on a different population sample and/or have not
agreed on all findings, partly because of the variation in the surgi-
cal protocol, and data collection/analysis method or follow-up
duration. Additionally, many of these studies have been performed
on a few eyes15,16,20,21,23 and have used a format which is different
from that recommended25,26 in presenting their graphic data, thus
making it difficult to directly compare results between studies.25,26
This study has been carried out in a population different from those
of previous studies and with a high incidence of keratoconus.5,30
We have also recruited more eyes than in previous stud-
ies15,16,20,21,23 and have monitored the changes from 6 months up
until 12 months after the procedure—a follow-up period that is
longer than those of previous studies.20–22
The impact of CXL combined with TG-PRK in patients’ self-
reported quality of life has been reported previously using various
validated tools.9,12,23 Labiris et al.,13 in a controlled study, reported
that CXL combined with TG-PRK offered an improved self-
reported quality of life in patients after treatment, but the scores
of the patients with keratoconus were significantly lower than those
of the matched healthy controls. The authors concluded that the
technique should be implemented as soon as possible for the treat-
ment of keratoconus.9 Analysis of the questionnaire scores used in
the current study also showed that many of the patients (79%) were
satisfied with the outcome of the procedure. No eye progressed as
evidenced from the keratometry readings shown in Table 1. The
use of a different assessment questionnaire in our study makes it
difficult to directly compare our results with those of Labiris et al.9
Despite the observed significant visual improvements in this
study, it lacked a control group and neither corneal endothelial cell
counts nor corneal biomechanical properties were assessed. Future
studies should consider monitoring these parameters for a long
term to better understand the changes observed using the two-step
surgical procedure. In this study, we were concerned with the
changes that were observed on completion of the second step
procedure, and as such, measurements of the reported parameters
were obtained only after the procedure has been completed. It has
been shown that the addition of the second step improves visual
outcomes beyond the improvements observed after the first step
procedure,15–18 and we have shown that between 6 and 12 months
after the procedure, there were further improvements in CDVA
while other visual functions were almost stable. We also waited
for 6 months after the first step before the second step procedure
was performed, but in future, earlier intervention can be consid-
ered, provided the stability of refraction is confirmed in two or
three visits of the patient. Additionally, the authors reason that
a better biomechanical strength could be achieved without inducing
any refractive surprises, if a flash CXL (half dose: 30 min ribofla-
vin plus 15 min UV@3 mW/cm2) is used rather than the full CXL,
which is commonly used in keratoconus.
In summary, the study reaffirms that ISCR implantation
followed no less than 6 months later by same-day TG-PRK/CXL
(two-step procedure)—for the treatment of moderate keratoconus
—is a safe and effective procedure that offers patients functional
visual acuity and satisfactory vision, which were maintained with
almost no postsurgical complication. It also seems to halt the pro-
gression of the disorder and studies with much longer follow-up
TABLE 2. Summary of Authors and Their Study Results for PRK Combined With Cross-linking in the Management of Keratoconus in Relation to the
Findings of the Current StudyAU14
Author Year Sample Size
Follow-up
Period Treatment Modality Major Findings
Kanellopoulos and
Binder14
2007 2 eyes 18 mo CXL+TG-PRK 12 mo after Significant improvement in vision
Kymionis et al.10 2009 12 pxs 10.69 mo Customized TG-PRK+same-day
CXL
Significant improvement in vision
Kanellopoulos24 2009 127 eyes (group 1) 36 mo CXL+TG-PRK 6 mo after vs Significant improvement in both but better in group 2
198 eyes (group 2) CXL+TG-PRK same day (Athens
Protocol)
Less corneal haze in group 2
Krueger and
Kanellopoulos33
2010 1 eye 30 mo Athens Protocol Significant improvement in CDVA, UDVA unchanged
Iovieno et al.21 2011 5 eyes 6 mo PRK+CXL same day Significant improvement in UDVA, no CDVA lines lost
Tuwairqi and Sinjab12 2012 22 eyes 12 mo CXL+TG-PRK same day Safety index 1.6, efficacy index 0.4
Lin et al.35
(retrospective)
2012 72 eyes 12 mo PRK/CXL Significant improvement in UDVA, CDVA but 16.5% lost
lines in CDVA
Alessio et al.36 2013 34 eyes 24 mo PRK+CXL vs CXL alone Combined procedure better than CXL alone
Coskunseven et al.22 2013 16 eyes 6 mo PRK+CXL 6 mo after Significant improvement in vision
Kanellopoulos and
Asimellis31
2014 231 eyes 3 yrs Athens Protocol Combined technique could lead to overcorrection
Zeraid et al.37 2014 21 eyes 6 mo CXL+TG-PRK same day Significant improvement in vision
No change in CCT and coma
CDVA, corrected distance visual acuity; CXL, corneal collagen cross-linking; TG-PRK, topography-guided photorefractive keratectomy;
UDVA, uncorrected distance visual acuity.
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periods are needed. Practitioners are encouraged to adopt a stan-
dardized protocol for reporting their results and to aid easy visu-
alization and direct comparison of results between studies.
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